Can someone start a journal called “Cell Atlases” so that the rest of the journals can go back to publishing interesting things?

This article should be mandatory reading for every medical student, PhD candidate, researcher—and honestly, for anyone who mistakes expertise for certainty. “The importance of stupidity in scientific research” sounds provocative, almost offensive. But Martin Schwartz is not glorifying incompetence. He is describing the real operating system of discovery. Science is not built on knowing. Science is built on tolerating not knowing. That distinction matters. Most of education rewards correctness. School teaches us to answer. Exams reward speed, certainty, and precision. You feel intelligent when you get things right. Research is the opposite. Real research begins exactly where competence ends—at the frontier where nobody knows the answer, including the people you thought must know. That moment is psychologically brutal. You ask the expert. The expert shrugs. You assume you’re missing something. Then you realize: no—this is the work. You are not failing. You are standing at the actual boundary of knowledge. That feeling—“I must be stupid”—is often not a sign of inadequacy. It is often the first sign that you are finally asking an important question. Medicine struggles with this. We train doctors to avoid uncertainty, to fear being wrong, to perform confidence. But the best clinicians and the best scientists know how to sit inside ambiguity without collapsing into fake certainty. This is why AI in medicine also deserves caution. Systems trained only to reproduce established answers may become extraordinarily good at passing exams while being terrible at discovering what matters next. Guideline intelligence is not the same as scientific intelligence. Discovery requires productive stupidity: the willingness to stay with the uncomfortable, to look ignorant, to ask naïve questions, to be wrong repeatedly without protecting your ego. Most people want the authority of expertise. Very few want the humiliation required to earn it. But progress lives there. Not in certainty. Not in performance. Not in sounding smart. In the quiet discipline of saying: “I don’t know… yet.” And continuing anyway.

Sci-Hub is an evil website that pirated 85M research papers and made them freely available And now they've added AI to their database to make Sci-Bot. It answers your questions using latest, full-text articles. But DO NOT use it. We should all try to make billion-dollar academic publishers richer. I'm putting the link below so you know how to avoid it.

Now that everyone is an expert on curing pancreatic cancer in mice, not rats - I want to add some context that goes beyond the headline. You will want to read this. Cancer is cured in mice all the time. Thousands of times. ~90% of those “cures” fail in humans. Why? Because mice are: Genetically simpler. Treated earlier. Short-lived. Not humans. Mice are a filter - not a finish line. Yes, this study matters. It comes from the Spanish National Cancer Research Centre. Yes, it’s pancreatic cancer - one of the deadliest there is. Yes, full tumor regression is impressive. But here’s what it actually means: “This approach is now good enough to risk years, trials, and millions of euros on.” Not: “Cancer is solved.” What happens next? More animal work. Toxicology. Phase I (safety). Phase II (maybe works). Phase III (beats standard care?). Maybe 8-10 years if everything goes right. The real damage isn’t failed drugs. It’s failed expectations. Every “cured cancer in mice” headline trains the public to believe: Cures are being hidden. Progress should be fast. Scientists are lying when reality hits. That’s how trust erodes. Bottom line: This is how real cancer progress looks. Messy. Slow. Risky. Incremental. Not miracles. Not conspiracies. Just science - doing the hard work.

Recover up to 60% more cells & get higher-quality libraries that can be sequenced at lower costs than manual methods? It’s possible with Chromium.

Parte del trabajo de un investigador (del @csic, de universidades) es viajar. A congresos, reuniones de trabajo, salidas al campo, etc. Sería razonable pensar que, cuando viajamos por trabajo, nuestro empleador cubre nuestros gastos. Pero no es así. Te lo explico. ->

Thrilled to report Patho-DBiT, just published in Cell 😊. It allows us to directly “see” all kinds of RNA species on the same clinical FFPE tissue slide, including mRNA, miRNA, snRNA, snoRNA, tRNA, etc, and splicing isoforms, genetic alterations (SNV, CNV, etc). Really a fun, cool, and powerful tool to explore human biology 🤩🤩 @CellCellPress cell.com/cell/fulltext/S0092…

Celebrating Xenopat’s 10th Anniversary! 🎂 We are thrilled to be celebrating a decade of innovation, collaboration, and progress at Xenopat! Today, we’d love to share our journey and some fascinating insights into our history. 🧵⬇️

Imagine seeing a disease's impact on every cell in the body. Now, you can! We introduce MouseMapper, an AI tool to reveal system-wide disease perturbations. MouseMapper showed obesity-induced changes in facial nerves & body-wide inflammation 👉🏼🧵biorxiv.org/content/10.1101/…